| Pharmaceutical active ingredients: |
| Pentaerithrityl Tetranitrate |
| Available forms, composition and doses of Nitropenton: |
| N / A |
| Nitropenton medical category: |
| Human:Vasodilating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DA05 - Pentaerithrityl Tetranitrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Egis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nitrinol | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitrodex | Pentaerithrityl Tetranitrate | Dexo Laboratoires; Actipharm; F. Uhlmann-Eyraud; Interlabo |
| Nitrolong | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitropent | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitropenta | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitro-Riletten | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Nitrotalans | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pencard | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentafin | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Pentalong | Pentaerithrityl Tetranitrate | Alpharma |